Promis Neurosciences Inc (PMN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 0 | 21 | 11 | 46 | 12 |
| Accounts receivable | N/A | N/A | N/A | -17 | 27 |
| Accounts payable and accrued liabilities | -6,106 | 4,963 | 2,676 | -32 | 73 |
| Other Working Capital | -11,730 | 2,945 | 5,403 | -1,560 | 688 |
| Other Operating Activity | -9,347 | -18,773 | -25,123 | -7,722 | -4,215 |
| Operating Cash Flow | $-27,182 | $-10,844 | $-17,034 | $-9,285 | $-3,415 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | 0 | -2 | 92 | -85 |
| Net Acquisitions | N/A | N/A | N/A | 2 | -2 |
| Purchase Of Investment | -33 | -32 | -31 | -33 | -33 |
| Sale Of Investment | 32 | 31 | 31 | 33 | 33 |
| Investing Cash Flow | $-1 | $-1 | $-2 | $94 | $-88 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 0 | 6,828 | N/A |
| Common Stock Issued | 27,848 | 17,745 | 4,974 | 20,017 | 0 |
| Common Stock Repurchased | N/A | N/A | N/A | -1,644 | N/A |
| Other Financing Activity | 28 | 4 | 1,520 | 0 | 3,007 |
| Financing Cash Flow | $27,876 | $17,749 | $6,495 | $25,202 | $3,007 |
| Exchange Rate Effect | 0 | -181 | -527 | N/A | N/A |
| Beginning Cash Position | 12,598 | 5,876 | 16,944 | 807 | 1,303 |
| End Cash Position | 13,291 | 12,598 | 5,876 | 16,819 | 807 |
| Net Cash Flow | $693 | $6,904 | $-10,541 | $16,012 | $-496 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,182 | -10,844 | -17,034 | -9,285 | -3,415 |
| Capital Expenditure | N/A | N/A | -2 | -6 | -85 |
| Free Cash Flow | -27,182 | -10,844 | -17,036 | -9,291 | -3,500 |